Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07457346) titled 'A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer' on March 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Condition:
Head and Neck Cancer Squamous Cell Carcinoma
Intervention:
Drug: cisplatin+ nab-paclitaxel +adebrelimab + imaxitinib
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: January 1, 2026
Target Sample Size...